Apigenin attenuates atherosclerosis and non-alcoholic fatty liver disease through inhibition of NLRP3 inflammasome in mice
Crossref DOI link: https://doi.org/10.1038/s41598-023-34654-2
Published Online: 2023-05-17
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lu, Zheng
Liu, Lu
Zhao, Shunxin
Zhao, Jiangtao
Li, Sujun
Li, Mingyang
Text and Data Mining valid from 2023-05-17
Version of Record valid from 2023-05-17
Article History
Received: 17 November 2022
Accepted: 4 May 2023
First Online: 17 May 2023
Competing interests
: The authors declare no competing interests.